Every day, physicians at Monroe Carell Jr. Children’s Hospital at Vanderbilt are looking for new and effective ways to care for their patients. Often that mission is carried out through clinical, basic and translational research across the institution and disciplines.

Throughout his career in medicine, Michael R. DeBaun, M.D., has found moments to fight the status quo.

Michael R. DeBaun, M.D., J.C. Peterson Professor of Pediatrics and Medicine at Vanderbilt, will be the keynote speaker at the 13th Annual Levi Watkins Jr. Lecture.

The Vanderbilt Cardio-Oncology program has fostered a special collaborative relationship combining the expertise of cardiologists and oncologists to understand the effects of cancer therapy on the heart. This type of collaboration is now helping to define the cardiovascular health of more than 14 million cancer survivors in the United States.

The Nashville Predators Foundation recently presented a $318,242 check to Monroe Carell Jr. Children’s Hospital at Vanderbilt for the 365 Pediatric Cancer Fund.

Vanderbilt-led research found regular blood transfusion therapy significantly reduces the recurrence of strokes in children with sickle cell anemia who have previously had "silent" strokes.

Michael R. DeBaun, M.D., MPH, has been recognized by the American Society of Hematology (ASH) for his significant contributions and research advances in the area of sickle cell disease.